SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Bjurström Johan)
 

Search: WFRF:(Bjurström Johan) > Amide hydrolysis of...

  • Bylund, Johan,1970-Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Biokemisk farmakologi (author)

Amide hydrolysis of a novel chemical series of microsomal prostaglandin e synthase-1 inhibitors induces kidney toxicity in the rat

  • Article/chapterEnglish2013

Publisher, publication year, extent ...

  • 2013-01-02
  • American Society for Pharmacology & Experimental Therapeutics (ASPET),2013
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-196595
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-196595URI
  • https://doi.org/10.1124/dmd.112.048983DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • A novel microsomal prostaglandin E synthase 1 (mPGES-1) inhibitor induced kidney injury at exposures representing less than 4 times the anticipated efficacious exposure in man during a 7-day toxicity study in rats. The findings consisted mainly of tubular lesions and the presence of crystalline material and increases in plasma urea and creatinine. In vitro and in vivo metabolic profiling generated a working hypothesis that a bis-sulfonamide metabolite (determined M1) formed by amide hydrolysis caused this toxicity. To test this hypothesis, rats were subjected to a 7-day study and were administered the suspected metabolite and two low-potency mPGES-1 inhibitor analogs, where amide hydrolysis was undetectable in rat hepatocyte experiments. The results suggested that compounds with a reduced propensity to undergo amide hydrolysis, thus having less ability to form M1, reduced the risk of inducing kidney toxicity. Rats treated with M1 alone showed no histopathologic change in the kidney, which was likely related to underexposure to M1. To circumvent rat kidney toxicity, we identified a potent mPGES-1 inhibitor with a low propensity for amide hydrolysis and superior rat pharmacokinetic properties. A subsequent 14-day rat toxicity study showed that this compound was associated with kidney toxicity at 42, but not 21, times the anticipated efficacious exposure in humans. In conclusion, by including metabolic profiling and exploratory rat toxicity studies, a new and active mPGES-1 inhibitor with improved margins to chemically induced kidney toxicity in rats has been identified.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Annas, Anita (author)
  • Hellgren, Dennis (author)
  • Bjurström, Sivert (author)
  • Andersson, Håkan (author)
  • Svanhagen, Alexander (author)
  • Uppsala universitetInstitutionen för farmaceutisk biovetenskap (creator_code:org_t)

Related titles

  • In:Drug Metabolism And Disposition: American Society for Pharmacology & Experimental Therapeutics (ASPET)41:3, s. 634-6410090-95561521-009X

Internet link

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view